MedTrace Logo

Coagulopathy in Acute Aortic Syndrome

NCT05149261 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-12-08

No results posted yet for this study

Summary

The existence of AAS coagulopathy has been reported, related to blood contact with the walls of the non-endothelialized false lumens. It is likely that endothelial dysfunction generated by vascular lesions may largely contribute to the development of coagulopathy, such as described in trauma-induced coagulopathy. This endotheliopathy of the AAS has never been evaluated. The coagulopathy of AAS and more specifically the endotheliopathy are poorly described and therefore have no standardized treatment.

The main objective of this study is to describe the coagulopathy

Conditions

  • Coagulopathy

Sponsors & Collaborators

  • European Georges Pompidou Hospital

    lead OTHER

Principal Investigators

  • Diane Zlotnik, MD · European Georges Pompidou Hospital

  • Anne Godier, MD-PhD · European Georges Pompidou Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05149261 on ClinicalTrials.gov